Follow
Osman Karaman
Title
Cited by
Cited by
Year
Mitochondria‐targeting selenophene‐modified BODIPY‐based photosensitizers for the treatment of hypoxic cancer cells
O Karaman, T Almammadov, M Emre Gedik, G Gunaydin, S Kolemen, ...
ChemMedChem 14 (22), 1879-1886, 2019
432019
Xanthene dyes for cancer imaging and treatment: A material odyssey
O Karaman, GA Alkan, C Kizilenis, CC Akgul, G Gunbas
Coordination Chemistry Reviews 475, 214841, 2023
222023
Synthesis of N-Bridged Pyrido[4,3-d]pyrimidines and Self-Assembly into Twin Rosette Cages and Nanotubes in Organic Media
C Igci, O Karaman, Y Fan, AA Gonzales III, H Fenniri, G Gunbas
Scientific Reports 8 (1), 15949, 2018
72018
Selenophene-modified boron dipyrromethene-based photosensitizers exhibit photodynamic inhibition on a broad range of bacteria
AC Ozketen, O Karaman, A Ozdemir, I Soysal, C Kizilenis, ...
ACS omega 7 (38), 33916-33925, 2022
62022
Balanced intersystem crossing in iodinated silicon-fluoresceins allows new class of red shifted theranostic agents
S Cetin, Z Elmazoglu, O Karaman, H Gunduz, G Gunbas, S Kolemen
ACS medicinal chemistry letters 12 (5), 752-757, 2021
52021
Superior Photodynamic Therapy of Colon Cancer Cells by Selenophene‐BODIPY‐Loaded Superparamagnetic Iron Oxide Nanoparticles
KN Ozvural Sertcelik, O Karaman, T Almammadov, G Gunbas, S Kolemen, ...
ChemPhotoChem 6 (10), e202200104, 2022
22022
Synthesis and in vitro studies of selenophene containingbodipy derivatives as mitochondria targetedphotodynamic therapy agents
O Karaman
Middle East Technical University), 2019
12019
NIR ABSORBING PHENOSELENAZINE BASED PDT AGENTS TOWARDS EFFECTIVE TREATMENT OF TRIPLE NEGATIVE BREAST CANCER
O Karaman, EG Günbaş
2023
Near-infrared (nir) absorbing photosensitizers
G Gunbas, S Kolemen, O Karaman, G Atakan, T Almammadov
US Patent App. 16/973,435, 2021
2021
Osman Karaman
O Karaman
2020
Supramoleküler kimya ile homojen ve heterojen kataliz arasında köprü kurmak
O Karaman, C İğci, EG Günbaş
null, 2017
2017
The system can't perform the operation now. Try again later.
Articles 1–11